TRELSTAR Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Trelstar, and when can generic versions of Trelstar launch?
Trelstar is a drug marketed by Verity and is included in three NDAs. There is one patent protecting this drug.
This drug has forty-seven patent family members in thirty-two countries.
The generic ingredient in TRELSTAR is triptorelin pamoate. There are three drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the triptorelin pamoate profile page.
DrugPatentWatch® Generic Entry Outlook for Trelstar
Trelstar was eligible for patent challenges on June 15, 2004.
By analyzing the patents and regulatory protections it appears that the earliest date
for generic entry will be June 30, 2029. This may change due to patent challenges or generic licensing.
Indicators of Generic Entry
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for TRELSTAR?
- What are the global sales for TRELSTAR?
- What is Average Wholesale Price for TRELSTAR?
Summary for TRELSTAR
International Patents: | 47 |
US Patents: | 1 |
Applicants: | 1 |
NDAs: | 3 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 48 |
Clinical Trials: | 11 |
Patent Applications: | 2,083 |
Drug Prices: | Drug price information for TRELSTAR |
What excipients (inactive ingredients) are in TRELSTAR? | TRELSTAR excipients list |
DailyMed Link: | TRELSTAR at DailyMed |


DrugPatentWatch® Estimated Loss of Exclusivity (LOE) Date for TRELSTAR
Generic Entry Date for TRELSTAR*:
Constraining patent/regulatory exclusivity:
NDA:
Dosage:
INJECTABLE;INTRAMUSCULAR |
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
Recent Clinical Trials for TRELSTAR
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Prostate Cancer Foundation | Phase 2 |
Panbela Therapeutics | Phase 2 |
Bristol-Myers Squibb | Phase 2 |
US Patents and Regulatory Information for TRELSTAR
TRELSTAR is protected by one US patents.
Based on analysis by DrugPatentWatch, the earliest date for a generic version of TRELSTAR is ⤷ Try for Free.
This potential generic entry date is based on patent ⤷ Try for Free.
Generics may enter earlier, or later, based on new patent filings, patent extensions, patent invalidation, early generic licensing, generic entry preferences, and other factors.
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Verity | TRELSTAR | triptorelin pamoate | INJECTABLE;INTRAMUSCULAR | 020715-001 | Jun 15, 2000 | RX | Yes | Yes | ⤷ Try for Free | ⤷ Try for Free | ⤷ Try for Free | ||||
Verity | TRELSTAR | triptorelin pamoate | INJECTABLE;INTRAMUSCULAR | 021288-001 | Jun 29, 2001 | RX | Yes | Yes | ⤷ Try for Free | ⤷ Try for Free | ⤷ Try for Free | ||||
Verity | TRELSTAR | triptorelin pamoate | INJECTABLE;INTRAMUSCULAR | 022437-001 | Mar 10, 2010 | RX | Yes | Yes | ⤷ Try for Free | ⤷ Try for Free | Y | ⤷ Try for Free | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for TRELSTAR
International Patents for TRELSTAR
When does loss-of-exclusivity occur for TRELSTAR?
Based on analysis by DrugPatentWatch, the following patents block generic entry in the countries listed below:
African Regional IP Organization (ARIPO)
Patent: 00
Patent: Slow release pharmaceutical composition made of microparticles
Estimated Expiration: ⤷ Try for Free
Australia
Patent: 08259411
Patent: Slow release pharmaceutical composition made of microparticles
Estimated Expiration: ⤷ Try for Free
Brazil
Patent: 0812250
Patent: COMPOSIÇÃO FARMACÊUTICA DE LIBERAÇÃO LENTA FEITA DE MICROPARTÍCULAS
Estimated Expiration: ⤷ Try for Free
Canada
Patent: 88478
Patent: COMPOSITION PHARMACEUTIQUE A LIBERATION LENTE, FAITE DE MICROPARTICULES (SLOW RELEASE PHARMACEUTICAL COMPOSITION MADE OF MICROPARTICLES)
Estimated Expiration: ⤷ Try for Free
China
Patent: 1677959
Patent: Slow release pharmaceutical composition made of microparticles
Estimated Expiration: ⤷ Try for Free
Colombia
Patent: 51234
Patent: COMPOSICIONES QUE COMPRENDEN MICROPARTICULAS DE UN COPOLIMERO DE ACIDO LACTICO Y GLICOLICO (PLGA) CON UNA SUSTANCIA ACTIVA EN LA FORMA DE UNA SAL PEPTIDICA INSOLUBLE
Estimated Expiration: ⤷ Try for Free
Croatia
Patent: 0161785
Estimated Expiration: ⤷ Try for Free
Patent: 0181854
Estimated Expiration: ⤷ Try for Free
Cyprus
Patent: 18434
Estimated Expiration: ⤷ Try for Free
Patent: 20891
Estimated Expiration: ⤷ Try for Free
Denmark
Patent: 64467
Estimated Expiration: ⤷ Try for Free
Patent: 00014
Estimated Expiration: ⤷ Try for Free
Eurasian Patent Organization
Patent: 9284
Patent: ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ С ПРОЛОНГИРОВАННЫМ ВЫСВОБОЖДЕНИЕМ, ПРИГОТОВЛЕННАЯ ИЗ МИКРОЧАСТИЦ (SLOW RELEASE PHARMACEUTICAL COMPOSITION MADE OF MICROPARTICLES)
Estimated Expiration: ⤷ Try for Free
Patent: 0971132
Patent: ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ С ПРОЛОНГИРОВАННЫМ ВЫСВОБОЖДЕНИЕМ, ПРИГОТОВЛЕННАЯ ИЗ МИКРОЧАСТИЦ
Estimated Expiration: ⤷ Try for Free
European Patent Office
Patent: 64467
Patent: COMPOSITION PHARMACEUTIQUE À LIBÉRATION LENTE, FAITE DE MICROPARTICULES (SLOW RELEASE PHARMACEUTICAL COMPOSITION MADE OF MICROPARTICLES)
Estimated Expiration: ⤷ Try for Free
Patent: 00014
Patent: Composition pharmaceutique à libération lente, faite de microparticules (Slow release pharmaceutical composition made of microparticles)
Estimated Expiration: ⤷ Try for Free
Patent: 31077
Patent: COMPOSITION PHARMACEUTIQUE À LIBÉRATION LENTE FABRIQUÉE À PARTIR DE MICROPARTICULES (SLOW RELEASE PHARMACEUTICAL COMPOSITION MADE OF MICROPARTICLES)
Estimated Expiration: ⤷ Try for Free
Finland
Patent: 00014
Estimated Expiration: ⤷ Try for Free
Hong Kong
Patent: 41737
Patent: SLOW RELEASE PHARMACEUTICAL COMPOSITION MADE OF MICROPARTICLES
Estimated Expiration: ⤷ Try for Free
Hungary
Patent: 31550
Estimated Expiration: ⤷ Try for Free
Patent: 40391
Estimated Expiration: ⤷ Try for Free
Israel
Patent: 2501
Patent: תכשירים המכילים מיקרו חלקיקים לשחרור מבוקר של טריפטולרין ושימוש בהם להכנת תרופה לטיפול בסרטן הערמונית (Pharmaceutical composition made of microparticles for controlled release of triptorelin and use thereof for the manufacture of a drug for the treatment of prostate cancer)
Estimated Expiration: ⤷ Try for Free
Japan
Patent: 19169
Estimated Expiration: ⤷ Try for Free
Patent: 10529106
Estimated Expiration: ⤷ Try for Free
Lithuania
Patent: 64467
Estimated Expiration: ⤷ Try for Free
Patent: 00014
Estimated Expiration: ⤷ Try for Free
Malaysia
Patent: 0450
Patent: SLOW RELEASE PHARMACEUTICAL COMPOSITION MADE OF MICROPARTICLES
Estimated Expiration: ⤷ Try for Free
Mexico
Patent: 09012856
Patent: COMPOSICION FARMACEUTICA DE LIBERACION LENTA HECHA DE MICROPARTICULAS. (SLOW RELEASE PHARMACEUTICAL COMPOSITION MADE OF MICROPARTICLES.)
Estimated Expiration: ⤷ Try for Free
Montenegro
Patent: 959
Patent: FARMACEUTSKA KOMPOZICIJA SA SPORIM OSLOBAĐANJEM KOJA JE FORMIRANA OD MIKROČESTICA (SLOW RELEASE PHARMACEUTICAL COMPOSITION MADE OF MICROPARTICLES)
Estimated Expiration: ⤷ Try for Free
Morocco
Patent: 422
Patent: COMPOSITION PHARMACEUTIQUE A LIBERATION PROLONGEE CONSTITUEE DE MICROPARTICULES
Estimated Expiration: ⤷ Try for Free
New Zealand
Patent: 2423
Patent: SLOW RELEASE PHARMACEUTICAL COMPOSITION MADE OF MICROPARTICLES COMPRISING PLGA, LHRH AND LACTIC ACID
Estimated Expiration: ⤷ Try for Free
Poland
Patent: 64467
Estimated Expiration: ⤷ Try for Free
Patent: 00014
Estimated Expiration: ⤷ Try for Free
Portugal
Patent: 64467
Estimated Expiration: ⤷ Try for Free
Patent: 00014
Estimated Expiration: ⤷ Try for Free
Serbia
Patent: 591
Patent: FARMACEUTSKA KOMPOZICIJA SA SPORIM OSLOBAĐANJEM PRIPREMLJENA OD MIKROČESTICA (SLOW RELEASE PHARMACEUTICAL COMPOSITION MADE OF MICROPARTICLES)
Estimated Expiration: ⤷ Try for Free
Patent: 248
Patent: FARMACEUTSKA KOMPOZICIJA SA SPORIM OSLOBAĐANJEM PRIPREMLJENA OD MIKROČESTICA (SLOW RELEASE PHARMACEUTICAL COMPOSITION MADE OF MICROPARTICLES)
Estimated Expiration: ⤷ Try for Free
Slovenia
Patent: 64467
Estimated Expiration: ⤷ Try for Free
Patent: 00014
Estimated Expiration: ⤷ Try for Free
South Africa
Patent: 0907940
Patent: Slow release pharmaceutical composition made of microparticles
Estimated Expiration: ⤷ Try for Free
South Korea
Patent: 1631475
Estimated Expiration: ⤷ Try for Free
Patent: 100023950
Patent: SLOW RELEASE PHARMACEUTICAL COMPOSITION MADE OF MICROPARTICLES
Estimated Expiration: ⤷ Try for Free
Spain
Patent: 11020
Estimated Expiration: ⤷ Try for Free
Patent: 94401
Estimated Expiration: ⤷ Try for Free
Tunisia
Patent: 09000476
Patent: SLOW RELEASE PHARMACEUTICAL COMPOSITION MADE OF MICROPARTICLES
Estimated Expiration: ⤷ Try for Free
Ukraine
Patent: 830
Patent: ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ С ПРОЛОНГИРОВАННЫМ ВЫСВОБОЖДЕНИЕМ, ИЗГОТОВЛЕННАЯ ИЗ МИКРОЧАСТИЦ;ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ З ПРОЛОНГОВАНИМ ВИВІЛЬНЕННЯМ, ВИГОТОВЛЕНА З МІКРОЧАСТИНОК (SLOW RELEASE PHARMACEUTICAL COMPOSITION MADE OF MICROPARTICLES)
Estimated Expiration: ⤷ Try for Free
Generics may enter earlier, or later, based on new patent filings, patent extensions, patent invalidation, early generic licensing, generic entry preferences, and other factors.
See the table below for additional patents covering TRELSTAR around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Sweden | 9103348 | ⤷ Try for Free | |
Denmark | 518988 | ⤷ Try for Free | |
South Africa | 8806827 | ⤷ Try for Free | |
Denmark | 175495 | ⤷ Try for Free | |
Japan | H01121222 | DRUG COMPOSITION FOR KEEPING AND REGULATING RELEASE OF DRUG OVER LONG TIME | ⤷ Try for Free |
Spain | 2020890 | PROCEDIMIENTO DE PREPARACION DE UNA COMPOSICION FARMACEUTICA EN FORMA DE MICROPARTICULAS. (METHOD FOR PREPARING A PHARMACEUTICAL COMPOSITION IN THE FORM OF MICROPARTICLES) | ⤷ Try for Free |
Croatia | P20161785 | ⤷ Try for Free | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Market Dynamics and Financial Trajectory for the Pharmaceutical Drug: TRELSTAR
More… ↓